Pre-surgical Aspirin Administration for Prevention of Thromboembolic Complication of Coil Embolization for Ruptured Cerebral Aneurysms - A-STOP study

Sumita Kazutaka0 个研究点目标入组 484 人开始时间: 2021年11月11日最近更新: 2023年10月17日

试验速览

暂无简介。

•1) Ruptured cerebral aneurysm in the acute phase
•2) Scheduled for aneurysm embolization within 72 hours of onset
•3) Aged 20 years or older at the time of onset
•4) Patients who have obtained written informed consent from the patient or his / her surrogate (spouse, parent, adult child, etc.) to participate in this study.

•1) Pre-stroke activity od daily living is not independent (pre-stroke mRS>3)
•2) Dissecting cerebral aneurysm who attempted parent artery occlusion
•3) Ruptured previously coil embolized cerebral aneurysm
•4) Ruptured infectious cerebral aneurysm or i cerebral aneurysm associated with cerebral arteriovenous malformation, moyamoya disease.
•5) Patients who are attempted simultaneously to treat two or more aneurysms
•6) Having already taken antiplatelet drugs
•7) History of allergies to lactose, aspirin, or salicyclic acid based preparations
•8) Cannot perform MRI
•9) Patinets who had a contraindications to aspirin
•10)Doctor in charge deems inappropriate to participate in this study

发起方

Sumita Kazutaka